Tag Archives: Sandostatin
Everolimus (Affinitor) Improves Survival in Pancreatic Neuroendocrine Tumors
Pancreatic neuroendocrine tumors affect the hormone-producing tissues within the pancreas, and have an incidence rate, affecting only 2 to 4 people per million worldwide. The incidence, however, is rising, and has quadrupled in the past 30 years, according to data … Continue reading
Posted in Cancer, Pancreatic Cancer
Tagged Affinitor, anthracyclines, Everolimus, fluoropyrimidines, Neuroendocrine tumor, octreotide, Pancreatic Cancer, Sandostatin, streptozocin, sunitinib, Survival, Sutent, Zanosar
Comments Off on Everolimus (Affinitor) Improves Survival in Pancreatic Neuroendocrine Tumors